FESARIUSTHERAPEUTICS INC ANNOUNCES FDA 510(K) CLEARANCE FOR DERMISPHERE HYDROGEL DERMAL REGENERATION TEMPLATE
Press Releases
FesariusTherapeutics Inc  
January 8, 2025

FESARIUSTHERAPEUTICS INC ANNOUNCES FDA 510(K) CLEARANCE FOR DERMISPHERE HYDROGEL DERMAL REGENERATION TEMPLATE

NEW YORK, Jan. 8, 2025 /PRNewswire/ -- FesariusTherapeutics Inc, an emerging bioregenerative technology company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care, Reconstructive Surgery

avatar profile Olean Times Herald

Olean Times Herald


Local & Social